about
Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)Cancer stem cell heterogeneity: origin and new perspectives on CSC targetingCocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.Chimeric antigen receptor T cells: a novel therapy for solid tumors.Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveFrom Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.Molecular markers in glioma.Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysisTetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.Cancer stem cell surface markers on normal stem cells.Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension.CD133 mRNA may be a suitable prognostic marker for human breast cancer.Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem CellsAptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial.Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma
P2860
Q27320830-96783A66-34DB-4D0F-894B-38A0A036E37DQ33649230-518836D0-0001-48A4-AC61-2FE9519EF26CQ37566921-5A76DC1F-2D33-4F84-9116-E5D47DCF3162Q37689910-98DF7765-9FFE-45B4-9ACF-0BD3C08B98C2Q37728639-4A06B545-DDE0-44DD-8D5E-A6ABEEC19B66Q38685020-2283749D-2012-445C-B0D0-B01DD0B01023Q39060269-83A9DCDB-FEF3-4DE7-AB8E-AB30DA00650EQ39148751-7456A3A3-BD39-4BD6-A6F8-7AFEF636A8D9Q41083994-A4BF40B8-80E0-4496-BF51-9E4A382080BCQ41094682-238DDF5B-A5E4-4E52-9641-D60ECE528D36Q42221543-45BE31B0-5980-4756-A006-923A00445F96Q42332008-66D8F3AF-64F4-4C87-A844-F791B5398F51Q46280894-D29E5803-5E78-44BC-8BBC-CB85788323E4Q47101214-A8C44E3D-4FA2-49B4-AA83-DD126978E5F6Q47107349-0E42228F-9B5D-4AAA-A4D2-F6B846965C8AQ47942947-CF12C3EE-C039-47EA-A3F5-B2620EE8E0B6Q50992976-7086480D-761A-459A-86E3-2F3D4AC9E0FBQ55477963-95111ABF-E014-4D3B-A101-F4591CF2C065Q58609015-A56EA777-6763-49FB-9BD0-CF8522654EFF
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
CD133, Selectively Targeting the Root of Cancer
@ast
CD133, Selectively Targeting the Root of Cancer
@en
CD133, Selectively Targeting the Root of Cancer
@nl
type
label
CD133, Selectively Targeting the Root of Cancer
@ast
CD133, Selectively Targeting the Root of Cancer
@en
CD133, Selectively Targeting the Root of Cancer
@nl
prefLabel
CD133, Selectively Targeting the Root of Cancer
@ast
CD133, Selectively Targeting the Root of Cancer
@en
CD133, Selectively Targeting the Root of Cancer
@nl
P2860
P921
P3181
P356
P1433
P1476
CD133, Selectively Targeting the Root of Cancer
@en
P2093
Daniel Vallera
Jörg Schmohl
P2860
P3181
P356
10.3390/TOXINS8060165
P407
P5008
P577
2016-05-28T00:00:00Z